<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04982640</url>
  </required_header>
  <id_info>
    <org_study_id>1U01AT011184</org_study_id>
    <nct_id>NCT04982640</nct_id>
  </id_info>
  <brief_title>Feasibility of Yoga for Type-2 Diabetes</brief_title>
  <official_title>Establishing Multi-site Feasibility and Fidelity of Yoga to Improve Management of Type-2 Diabetes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Miriam Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Miriam Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will randomize 90 adults with type-2 diabetes (T2DM) from three different states&#xD;
      (RI, MA, and AL) to a 12-week program of either (1) Iyengar yoga or (2) a Standard Exercise&#xD;
      program. Follow up assessments occur at 3 and 6-months post-intervention. Results of this&#xD;
      study will determine the ability to deliver these interventions with strong rigor and&#xD;
      fidelity across multiple sites and will establish the feasibility and acceptability of this&#xD;
      intervention across racially and ethnically diverse populations. The study will also examine&#xD;
      factors (e.g., outcome expectations, barriers to home practice) that promote long-term&#xD;
      adherence to yoga and/or physical activity.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 30, 2021</start_date>
  <completion_date type="Anticipated">May 30, 2024</completion_date>
  <primary_completion_date type="Anticipated">January 30, 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>Codes identifying randomization assignment are withheld from the research staff conducting study outcome assessments.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Feasibility assessed as session attendance</measure>
    <time_frame>12 weeks</time_frame>
    <description>Each participant is scheduled for 36 classes in total. The percent of classes attended is calculated for each participant to determine feasibility. If the average percentage of classes attended for all participants exceeds 70% the intervention will be deemed feasible.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Acceptability as indicated by participant satisfaction ratings</measure>
    <time_frame>12 weeks</time_frame>
    <description>The participant satisfaction scale contains 10 items using a Likert scale from 1 (not at all satisfied) to 5 (very satisfied). Scale items will be summed and averaged for each participant. Scores from all participants are averaged. If the overall average score from all participants is 4 or greater the program will be considered satisfactory.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hemoglobin A1c</measure>
    <time_frame>6 months</time_frame>
    <description>Changes in hemoglobin A1c (HbA1c) from baseline to 6 months follow up</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diabetes Distress as measured by the Problem Areas in Diabetes Scale</measure>
    <time_frame>12 weeks</time_frame>
    <description>The problem areas in diabetes scale is a valid and reliable measure of diabetes-related emotional distress. It contains 20 items using a Likert scale from 0 (not a problem) to 4 (serious problem). Scale items are summed and averaged. Higher scores indicate more serious emotional distress associated with managing diabetes.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fasting Blood Glucose</measure>
    <time_frame>12 weeks</time_frame>
    <description>Blood samples taken after &gt; 12 hour fast are assessed using standard laboratory protocols. FBG levels measured as mg/dL at 12 weeks will be compared with baseline values.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body Mass Index</measure>
    <time_frame>6 months</time_frame>
    <description>Measured as body weight in kilograms divided by height in meters squared. [kilograms]/ height [meters2]),</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Type2 Diabetes</condition>
  <arm_group>
    <arm_group_label>Yoga</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>12-week program, 60 minutes, twice weekly group-delivered Iyengar yoga</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard Exercise</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>12-week, 60 minutes, twice weekly group-delivered aerobic exercise (e.g., walking) program</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Iyengar yoga</intervention_name>
    <description>60 minute group-classes of Iyengar yoga delivered twice weekly for 12 weeks</description>
    <arm_group_label>Yoga</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Standard Exercise</intervention_name>
    <description>60 minutes, twice weekly for 12 weeks, group-based walking program</description>
    <arm_group_label>Standard Exercise</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Nutrition Counseling</intervention_name>
    <description>One, 30-minute session with registered dietitian</description>
    <arm_group_label>Standard Exercise</arm_group_label>
    <arm_group_label>Yoga</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Age 18 -74 years&#xD;
&#xD;
          2. Baseline HbA1c of 6.5 or greater&#xD;
&#xD;
          3. Physician clearance&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Serious comorbid condition (such as uncontrolled hypertension, glaucoma, heart&#xD;
             failure).&#xD;
&#xD;
          2. Complications of diabetes such as diabetic retinopathy, neuropathy and nephropathy&#xD;
&#xD;
          3. Serious psychiatric disorder (e.g. psychosis, major depression, panic attacks,&#xD;
             suicidality, or substance dependence).&#xD;
&#xD;
          4. Extremely obese (i.e. Body Mass Index &gt; 45 kg/m2)&#xD;
&#xD;
          5. Currently engaged in yoga, Tai Chi, or other mindfulness-based practice the past six&#xD;
             months&#xD;
&#xD;
          6. Pregnant or trying to become pregnant&#xD;
&#xD;
          7. Inability to read and write English&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>74 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Beth Bock, PhD</last_name>
    <phone>401*793*8020</phone>
    <email>Beth_Bock@Brown.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Kristen Walaska, BS</last_name>
    <phone>401-793-8022</phone>
    <email>KWalaska@Lifespan.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>The Miriam Hospital- CORO building</name>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <zip>02903</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>July 4, 2021</study_first_submitted>
  <study_first_submitted_qc>July 20, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 29, 2021</study_first_posted>
  <last_update_submitted>July 20, 2021</last_update_submitted>
  <last_update_submitted_qc>July 20, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The Miriam Hospital</investigator_affiliation>
    <investigator_full_name>Beth Bock, Ph.D.</investigator_full_name>
    <investigator_title>Senior Research Scientist</investigator_title>
  </responsible_party>
  <keyword>Diabetes</keyword>
  <keyword>Yoga</keyword>
  <keyword>Physical Activity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

